SARS-CoV-2 Ag + Influenza A + B

- +

Rapid immunochromatographic test for the qualitative detection of SARS-CoV-2, Influenza A and Influenza B virus antigens in nasopharyngeal swab specimens from individuals with suspected SARS-CoV-2 / Influenza infection in conjunction with clinical presentation and the results of other laboratory tests.

SARS-CoV-2 Ag
Relative Sensitivity: 96.4% (95% CI*: 89.8% - 99.2%)

Relative Specificity: 99.2% (95% CI*: 95.5% - 99.9%)

Accuracy: 98.0% (95% CI*: 95.1% - 99.5%)
* Confidence Intervals

Influenza type A

Relative Sensitivity: 94.1% (95% CI*: 71.3% - 99.9%)

Relative Specificity: 98.4% (95% CI*: 91.5% - >99.9%)

Accuracy: 97.5% (95% CI*: 91.3% - 99.7%) 98.8%
* Confidence Intervals

Influenza type B
Relative Sensitivity: 91.7% (95% CI*: 61.5% - 99.8%)

Relative Specificity: 100.0% (95% CI*: 95.7% - 100.0%)

Accuracy: 98.8% (95% CI*: 93.2% - >99.9%)

* Confidence Intervals

Express Tests
Using by a patient No
Test method Manual
General
Storage conditions 2 - 30°C
Country of Origin Italy
Average Delivery Time 3 weeks

Tags: Вирусные Вирусные Вирусные Вирусные Профессионально Профессионально Профессионально Профессионально Мазок Мазок Мазок Мазок COVID-19 COVID-19 COVID-19 COVID-19